Movement disorders Flashcards
Features of Parkinsonism
Akinesia, rigidity, tremor
Axial -postural instability, gait freezing
Essential feature -akinesia
Commonest cause of Parkinsonism
Parkinsons disease
Atypical Parkinsonism -MSA,CBD,PSP
Reversible parkinsonism
Drug induced
Metal deposition -copper, Mn
NPH
Features suggestive of Parkinsons disease
Anosmia
REM sleep disorder -acts out dreams
Substantial response to L-dopa (upto 50%)
Drug induced dyskinesias
New explaination of pathogenesis of Parkinsons disease
Exhibits protein self templating progression -similar to prion disease
Test to diagnose congnitive impairment in Parkinsons
Visuospatial impairment
Draw intersecting pentagons -if cannot -poor prognostic sign
Cognitive syndromes in Parkinsons
1.Frontal executive syndrome -present at diagnosis
Correlates with dopamine depletion
Does nor correlate with dementia
Responds to dopamine replacement
2.Posterior visuospatial syndrome
Sinister sign- correlates with dementia.
Cannot draw intersecting pentagons
Dopaminergic therapy for Rx
MAO -B inhibitors -selegiline, rasagiline
Dopamine agonists-Pramipexole, rotigotine,apomorphine
Levodopa(+/-COMT) -Sinemet, Kinson,Madopar (Entacapone)
Characteristics of MAO -B inhibitors
Simple dosing
Modest benefit
S/E insomnia
Low chance of serotonin syndrome with SSRI
Dopamine agonist characteristics
Benefit -improve mood,mood and motivation
S/E: Impulse control disorder*-hypersexuality,gambling
Sleeping, psychosis
Levodopa
Most effective drug for movement
S/E -motor fluctuations -10% per year from starting Rx
Risk factors for development of motor fluctuations
Age, duration of disease
Management of motor fluctutations with L dopa
Fractionation -smaller doses, frequent intervals
Advanced therapies for motor fluctations
Apomorphine via s/c infusion
Levo dopa via PEJ . Risk of peritonitis
Deep brain stimulation -subthalamic nucleus and GB interna
Dementia in Parkinsons - management
Cholinesterase inhibitor